Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study

Circulation. 2020 Jul 21;142(3):306-308. doi: 10.1161/CIRCULATIONAHA.120.047729. Epub 2020 Jul 20.

Kamil F Faridi^{1

2}, Hector Tamez², Jordan B Strom², Yang Song³, Neel M Butala⁴, Changyu Shen², Eric A Secemsky², Laura Mauri^{3

5}, Jeptha P Curtis¹, C Michael Gibson^{2

3}, Robert W Yeh^{2

4

3}

¹ Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT (K.F.F., J.P.C.).
² Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA (K.F.F., H.T., J.B.S., C.S., E.A.S., C.M.G., R.W.Y.).
³ Baim Institute for Clinical Research, Boston, MA (Y.S., L.M., C.M.G., R.W.Y.).
⁴ Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston (N.M.B., R.W.Y.).
⁵ Medtronic, Minneapolis, MN (L.M.).

No abstract available

Keywords: administrative claims, healthcare; clinical trial; coronary artery disease.

Publication types